Korea FDA Prepares Guidelines On Phase 0 Clinical Trials To Draw More Early-stage Trials
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Korea FDA is gearing up to release guidelines on Phase 0 clinical trials in the first half of next year under its broader ambition to draw more early-stage clinical trials to the country